Subramanyam Dasari
Oncology — Indiana University, United States
Subramanyam Dasari
LeadR Profile
Oncology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 38
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Vitamin K3 derivative inhibits androgen receptor signaling in targeting aggressive prostate cancer cells. cells, mortality, biochemistry, vitamin k 3, vitamins, androgens, acetylcysteine, receptors, androgen, neoplasms, prostate, antioxidants, cell line, prostatic neoplasms, nutritional physiological phenomena, therapeutics, apoptosis, cell death | Biofactors | 2024 | 0 |
| Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling. stem cells, ovarian neoplasms, microscopy, electron, scanning transmission, stem cell niche, carboplatin, wnt signaling pathway, cancer-associated fibroblasts | NPJ Precis Oncol | 2024 | 17 |
| Neferine Targets the Oncogenic Characteristics of Androgen-Dependent Prostate Cancer Cells via Inducing Reactive Oxygen Species. androgens, prostate, apoptosis, cells, therapeutics, prostatic neoplasms, autophagy | Int J Mol Sci | 2023 | 1 |
| Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis. neoplasm metastasis, therapeutics, neoplasms, tumor microenvironment | Front Mol Biosci | 2023 | 0 |
| Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer. ovarian neoplasms | Cancer Res | 2022 | 46 |
LeadR Networks
Main global connection map